Rate My Professor Charithani Keragala

Dr. Charithani Keragala serves as an Adjunct Lecturer in Medicine at Monash Health, School of Clinical Sciences at Monash University, and as a clinical and laboratory haematologist at Monash Health since 2013. She earned her MBBS with Honours, completed her PhD in 2023 at the Australian Centre for Blood Diseases focusing on the plasminogen activating system and its links with innate immunity, and became a Fellow of the Royal Australasian College of Physicians (FRACP) and the Royal College of Pathologists of Australasia (FRCPA) in 2018. Specializing in haemostasis and thrombosis-related medicine and fibrinolysis, Dr. Keragala's research explores plasminogen, complement activation, and the interplay between the fibrinolytic system and innate immune responses. As an early career clinician-scientist at the Australian Centre for Blood Diseases, she bridges clinical haematology with translational research.

Dr. Keragala has authored numerous publications in leading journals, contributing to advancements in thrombosis and haemostasis. Notable works include 'Plasminogen: an enigmatic zymogen' in Blood (2021), 'Haemostasis and innate immunity—a complementary relationship: A review of the intricate relationship between coagulation and complement pathways' in the British Journal of Haematology (2018), 'Fibrinolysis and COVID-19: a plasmin paradox' and 'Fibrinolysis and COVID-19: a tale of two sites' both in the Journal of Thrombosis and Haemostasis (2020), 'Tranexamic acid for haemostasis and beyond: does dose matter?' in Thrombosis Journal (2023), and 'Plasma from patients with vaccine-induced immune thrombotic thrombocytopenia displays increased fibrinolytic potential' in the Journal of Thrombosis and Haemostasis (2024). She has also contributed to the 'Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress' in Research and Practice in Thrombosis and Haemostasis (2024).

Her research excellence is recognized through awards such as the 2023 Eberhard F. Mammen Young Investigator Award for studies on vaccine-induced immune thrombotic thrombocytopenia and fibrinolysis, runner-up for best presentation at the national Blood conference (2018), John Lloyd Travel Grant from the Thrombosis and Haemostasis Society of Australia and New Zealand, third prize at the CCS Graduate Research Symposium (2018), and an ISTH Training Fellowship (2024). Dr. Keragala's work enhances understanding of coagulation, fibrinolysis, and immune interactions in conditions including stroke, sepsis, and thrombotic disorders.